• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

羧酰胺取代的阿片类药物的合成及阿片受体结合特性

Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.

作者信息

Wentland Mark P, Lou Rongliang, Lu Qun, Bu Yigong, VanAlstine Melissa A, Cohen Dana J, Bidlack Jean M

机构信息

Department of Chemistry and Chemical Biology, Rensselaer Polytechnic Institute, Troy, NY 12180, USA.

出版信息

Bioorg Med Chem Lett. 2009 Jan 1;19(1):203-8. doi: 10.1016/j.bmcl.2008.10.134. Epub 2008 Nov 7.

DOI:10.1016/j.bmcl.2008.10.134
PMID:19027293
Abstract

A series of 15 novel opioid derivatives were made where the prototypic phenolic-OH group of traditional opioids was replaced by a carboxamido (CONH(2)) group. For 2,6-methano-3-benzazocines and morphinans similar or, in a few instances, enhanced affinity for mu, delta and kappa opioid receptors was observed when the OH-->CONH(2) switch was applied. For 4,5alpha-epoxymorphinans, binding affinities for the corresponding carboxamide derivatives were much lower than the OH partner consistent with our pharmacophore hypothesis concerning carboxamide bioactive conformation. The active metabolite of tramadol and its carboxamide counterpart had comparable affinities for the three receptors.

摘要

制备了一系列15种新型阿片类衍生物,其中传统阿片类药物的原型酚羟基被羧酰胺(CONH₂)基团取代。对于2,6-亚甲基-3-苯并氮杂卓类和吗啡喃类,当进行OH→CONH₂转换时,观察到对μ、δ和κ阿片受体具有相似的亲和力,在少数情况下亲和力增强。对于4,5α-环氧吗啡喃类,相应羧酰胺衍生物的结合亲和力远低于羟基对应物,这与我们关于羧酰胺生物活性构象的药效团假说一致。曲马多的活性代谢物及其羧酰胺类似物对三种受体具有相当的亲和力。

相似文献

1
Syntheses and opioid receptor binding properties of carboxamido-substituted opioids.羧酰胺取代的阿片类药物的合成及阿片受体结合特性
Bioorg Med Chem Lett. 2009 Jan 1;19(1):203-8. doi: 10.1016/j.bmcl.2008.10.134. Epub 2008 Nov 7.
2
Syntheses of novel high affinity ligands for opioid receptors.新型阿片受体高亲和力配体的合成。
Bioorg Med Chem Lett. 2009 Apr 15;19(8):2289-94. doi: 10.1016/j.bmcl.2009.02.078. Epub 2009 Feb 25.
3
Syntheses and opioid receptor binding affinities of 8-amino-2,6-methano-3-benzazocines.8-氨基-2,6-亚甲基-3-苯并氮杂卓的合成及其对阿片受体的结合亲和力
J Med Chem. 2003 Feb 27;46(5):838-49. doi: 10.1021/jm020429w.
4
10-Ketomorphinan and 3-substituted-3-desoxymorphinan analogues as mixed kappa and micro opioid ligands: synthesis and biological evaluation of their binding affinity at opioid receptors.10-酮吗啡喃和3-取代-3-去氧吗啡喃类似物作为κ和μ阿片样物质混合配体:其对阿片受体结合亲和力的合成及生物学评价
J Med Chem. 2004 Jan 1;47(1):165-74. doi: 10.1021/jm0304156.
5
Synthesis and SAR study of opioid receptor ligands: mono- and bis-indolomorphinans.阿片受体配体的合成与构效关系研究:单吲哚吗啡喃和双吲哚吗啡喃
Chem Biol Drug Des. 2009 Oct;74(4):335-42. doi: 10.1111/j.1747-0285.2009.00849.x. Epub 2009 Aug 19.
6
Redefining the structure-activity relationships of 2,6-methano-3-benzazocines. 4. Opioid receptor binding properties of 8-[N-(4'-phenyl)-phenethyl)carboxamido] analogues of cyclazocine and ethylketocycalzocine.重新定义2,6-亚甲基-3-苯并氮杂䓬的构效关系。4. 环唑辛和乙基酮环唑辛的8-[N-(4'-苯基)-苯乙基]甲酰胺类似物的阿片受体结合特性。
J Med Chem. 2006 Sep 7;49(18):5635-9. doi: 10.1021/jm060278n.
7
Synthesis and biological evaluation of 14-alkoxymorphinans. 20. 14-phenylpropoxymetopon: an extremely powerful analgesic.14-烷氧基吗啡喃的合成与生物学评价。20. 14-苯丙氧基美托酮:一种极强效的镇痛药。
J Med Chem. 2003 Sep 11;46(19):4182-7. doi: 10.1021/jm030878b.
8
Structure-activity relationship studies of carboxamido-biaryl ethers as opioid receptor antagonists (OpRAs). Part 1.作为阿片受体拮抗剂(OpRAs)的羧酰胺基联芳基醚的构效关系研究。第1部分。
Bioorg Med Chem Lett. 2007 Oct 1;17(19):5349-52. doi: 10.1016/j.bmcl.2007.08.008. Epub 2007 Aug 11.
9
3-Carboxamido analogues of morphine and naltrexone. synthesis and opioid receptor binding properties.吗啡和纳曲酮的3-羧酰胺类似物。合成及阿片受体结合特性。
Bioorg Med Chem Lett. 2001 Jul 9;11(13):1717-21. doi: 10.1016/s0960-894x(01)00278-5.
10
Synthesis and opioid receptor binding properties of a highly potent 4-hydroxy analogue of naltrexone.纳曲酮高效4-羟基类似物的合成及其阿片受体结合特性
Bioorg Med Chem Lett. 2005 Apr 15;15(8):2107-10. doi: 10.1016/j.bmcl.2005.02.032.

引用本文的文献

1
N-(3-Hydroxyphenyl)-3,8-diazabicyclooctanes as opioid receptors probes. 1. Investigation of the phenolic hydroxyl group.N-(3-羟基苯基)-3,8-二氮杂双环辛烷作为阿片受体探针。1. 酚羟基的研究。
Eur J Med Chem. 2025 Nov 15;298:117991. doi: 10.1016/j.ejmech.2025.117991. Epub 2025 Jul 23.
2
Role of efficacy as a determinant of locomotor activation by mu-opioid receptor (MOR) ligands in female and male mice. II. Effects of novel MOR-selective phenylmorphans with high-to-low MOR efficacy.阿片受体(MOR)配体对雌性和雄性小鼠运动激活作用的功效决定作用。二、高至低 MOR 功效的新型 MOR 选择性苯吗喃的影响。
Pharmacol Res Perspect. 2023 Aug;11(4):e01111. doi: 10.1002/prp2.1111.
3
Mechanisms Underlying the Anti-Suicidal Treatment Potential of Buprenorphine.
丁丙诺啡抗自杀治疗潜力的潜在机制。
Adv Drug Alcohol Res. 2021;1. doi: 10.3389/adar.2021.10009. Epub 2021 Aug 3.
4
Construction of a Virtual Opioid Bioprofile: A Data-Driven QSAR Modeling Study to Identify New Analgesic Opioids.虚拟阿片类生物图谱的构建:一项用于识别新型镇痛阿片类药物的数据驱动定量构效关系建模研究
ACS Sustain Chem Eng. 2021 Mar 15;9(10):3909-3919. doi: 10.1021/acssuschemeng.0c09139. Epub 2021 Mar 4.
5
Mechanisms of QT prolongation by buprenorphine cannot be explained by direct hERG channel block.丁丙诺啡引起 QT 间期延长的机制不能用直接阻断 hERG 通道来解释。
PLoS One. 2020 Nov 6;15(11):e0241362. doi: 10.1371/journal.pone.0241362. eCollection 2020.
6
Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gz as Shown with Bioluminescence Resonance Energy Tranfer.Bioluminescence Resonance Energy Transfer Demonstrates Unique Pharmacological Properties of the Kappa Opioid Receptor Signaling Through Gz
Mol Pharmacol. 2020 Oct;98(4):462-474. doi: 10.1124/mol.120.119404. Epub 2020 Jul 27.
7
Toward a Universal μ-Agonist Template for Template-Based Alignment Modeling of Opioid Ligands.迈向用于阿片类配体基于模板对齐建模的通用μ-激动剂模板。
ACS Omega. 2019 Oct 9;4(17):17457-17476. doi: 10.1021/acsomega.9b02244. eCollection 2019 Oct 22.
8
Targeting opioid dysregulation in depression for the development of novel therapeutics.针对抑郁症中阿片类物质失调的靶点,开发新的治疗方法。
Pharmacol Ther. 2019 Sep;201:51-76. doi: 10.1016/j.pharmthera.2019.04.009. Epub 2019 Apr 30.
9
μ Opioid receptor: novel antagonists and structural modeling.μ阿片受体:新型拮抗剂与结构建模
Sci Rep. 2016 Feb 18;6:21548. doi: 10.1038/srep21548.
10
Evaluation of opioid modulation in major depressive disorder.重度抑郁症中阿片类药物调节作用的评估。
Neuropsychopharmacology. 2015 May;40(6):1448-55. doi: 10.1038/npp.2014.330. Epub 2014 Dec 18.